Capmatinib
Capmatinib has been used in trials studying the treatment of Melanoma, Gliosarcoma, Solid Tumors, Colorectal Cancer, and Hepatic Impairment, among others.Reference standards of Capmatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Capmatinib - API Standards
[catalogue_number] => PA 56 97000
[category_ids] => ,78,70,82,
[chemical_name] =>
[weight] => 412.43
[form] => C23H17FN6O
[cas] => 1029712-80-8
[pslug] => 1029712-80-8-capmatinib-api-pa5697000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Capmatinib - API Standards
Catalogue No.:PA 56 97000
Molecular Formula : C23H17FN6O
Molecular Weight : 412.43